BridgeMD
New treatment option for Leprosy
Official title Novel Interventions and Diagnostic Tests for Leprosy
ClinicalTrials.gov ID: NCT06222372
What this study is testing
What is Rifampin?
Rifampin is an investigational medicine, being studied as a potential treatment for leprosy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Contact with Mycobacterium leprae (M. leprae) infected individuals is a risk factor for development of leprosy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 and older. Healthy volunteers may be eligible.
You may be able to join if
- patients: \- newly diagnosed multibacillary leprosy patients (BI 1-6) contacts of MB leprosy patients:
- living in the same house (household members)
- living in a house on the same compound
- sharing the same kitchen
- direct neighbors (first neighbors)
You likely can't join if
- patients:
- refusal of examination of their contacts
- suffering from the pure neural form of leprosy
- residing only temporarily in the study area
- PB leprosy patients Exclusion Criteria contacts:
- diagnosed as leprosy patients during contact examination
See the full eligibility criteria
- patients: \- newly diagnosed multibacillary leprosy patients (BI 1-6) contacts of MB leprosy patients:
- living in the same house (household members)
- living in a house on the same compound
- sharing the same kitchen
- direct neighbors (first neighbors)
- willing to participate
- provide informed consent
- patients:
- refusal of examination of their contacts
- suffering from the pure neural form of leprosy
- residing only temporarily in the study area
- PB leprosy patients Exclusion Criteria contacts:
- diagnosed as leprosy patients during contact examination
- living less than 100 m away from a patient already included in the study
- first and second degree relatives of a patient already included in the study
- refusal informed consent
- pregnancy
- tuberculosis or leprosy treatment
- below 5 years of age
- known to suffer from liver disease or jaundice
- residing temporarily in the study area
The study team makes the final eligibility decision.
Where it's taking place
- Nilphamari, Bangladesh
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nilphamari, Bangladesh. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.